Advances in Cell and Gene Therapy and Opportunities in China

GenScript Biotech Corp., a leading global biotechnology group and a pioneer in the field of gene synthesis, held its ina...

January 16, 2020 | Thursday | Opinion
Tsinghua Amgen Scholars Program 2020 calls for application

The Amgen Scholars Program (ASP) is an international program funded by the Amgen Foundation with the direction of H...

January 15, 2020 | Wednesday | News
PPD expands clinical capabilities in China

PPD, Inc. ( PPD ) has expanded its China operations and leadership team to provide more international and Chin...

January 15, 2020 | Wednesday | News
Great Bay Bio injected with $2.5M of convertible note

Recently, Great Bay Bio signed off convertible note, and the company will be injected with 2.5 million USD by existing s...

January 14, 2020 | Tuesday | News
Adagene Completes $69 Million Series D Financing

China based Adagene, Inc., a clinical-stage, leading-edge oncology immunotherapy company driven by a powerful antibody d...

January 14, 2020 | Tuesday | News
EUSA Pharma, BeiGene partner for rare disease drug development

EUSA Pharma and BeiGene has announced that they have entered into an exclusive development and commercialization ag...

January 14, 2020 | Tuesday | News
Bio-Thera launches first Humira biosimilar in China

Bio-Thera Solutions, Ltd., a fully-integrated pharmaceutical company, has announced that QLETLI®, a biosimilar to Hu...

January 13, 2020 | Monday | News
WuXi Biologics inks strategic deal with Almirall in derma space

China based WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solut...

January 10, 2020 | Friday | News
Former Celgene Chairman and CEO Joins Antengene Board of Directors

The Antengene board has announced the appointment of Mr. Mark J. Alles as an independent director of the compa...

January 9, 2020 | Thursday | News
Eisai launches antiepileptic drug in China

Japan based Eisai Co., Ltd. has announced that it has launched the in-house discovered and developed antiepileptic drug ...

January 9, 2020 | Thursday | News
CStone initiates CS1001 trial to treat ESCC in China

CStone Pharmaceuticals has announced that the first patient has been dosed in the Phase III GEMSTONE-304 study of the Co...

January 8, 2020 | Wednesday | News
Innovent and Sirnaomics enter into strategic collaboration

China based Innovent Biologics, Inc., a world-class biopharmaceutical company that develops and commercializes high qual...

January 8, 2020 | Wednesday | News
China approves AstraZeneca’s Lokelma to treat hyperkalaemia

AstraZeneca’s Lokelma (sodium zirconium cyclosilicate) has been approved in China for the treatment of a...

January 7, 2020 | Tuesday | News
Yisheng inks oncology deal with Tavotek

China headquartered Yisheng Biopharma Co., Ltd., a biopharmaceutical company focusing on research, development, manufact...

January 7, 2020 | Tuesday | News
Antengene Corporation appoints former Celgene China GM John Chin as CBO

Antengene Corporation has announced its appointment of Mr. John Chin, MBA, as Chief Business Officer (CBO). He will be r...

January 7, 2020 | Tuesday | News
I-Mab Biopharma commences pivotal study of TJ202/MOR202 in China

I-Mab Biopharma ("I-Mab"), a global biopharmaceutical company based in China and the United States a...

January 6, 2020 | Monday | News
Leap, BeiGene to develop immunotherapy for gastric cancer

US based Leap Therapeutics, Inc. a biotechnology company developing targeted immuno-oncology therapeutics, and China hea...

January 6, 2020 | Monday | News
WuXi STA opens oligonucleotide large-scale manufacturing facility

STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec  has announced the opening of its...

January 3, 2020 | Friday | News